Accelr8 Press Release

---

Contact:
Thomas V. Geimer, CEO
Tel: 303-863-8088
tom.geimer@accelr8.com

---

Accelr8 Announces Second License To SCHOTT Nexterion

Accelr8 Technology Corporation (Amex:AXK) and SCHOTT Nexterion® (SCHOTT JENA^er GLAS GmbH, Jena, Germany) announced execution of a second OptiChem® license agreement to SCHOTT. The new license covers a second version of Accelr8's OptiChem coatings used in microarraying slides. The 2-year license grants SCHOTT the non-exclusive right to manufacture and sell Nexterion Slide HS microarraying slides that use the protein-containing coating. In return, SCHOTT has paid Accelr8 a license fee and pre-paid royalties. This agreement follows an earlier license for a different type of OptiChem, signed in 2004.

Slide HS provides a surface coated with streptavidin, which is a type of protein. The coating provides a uniform and stable surface to maximize detection sensitivity for research in disease markers for diagnostics and in drug discovery.

According to David Howson, Accelr8’s president, “SCHOTT has developed industrial and academic customers for Slide HS. One of their industrial customers has launched a protein microarray product line that uses our coatings because of their performance advantages. We are very pleased to expand our relationship with SCHOTT Nexterion as the microarraying market continues to develop. In particular, we look forward to participating in the molecular diagnostics market as microarraying matures.”

About Accelr8

Accelr8 Technology Corporation ( www.accelr8.com) is a developer of innovative materials and instrumentation for advanced applications in medical instrumentation, basic research, drug discovery, and bio-detection. Accelr8 is developing a rapid clinical pathogen platforms, the BACcel™-1.0 and the BACcelr8r™, based on its innovative surface coatings, assay processing, and detection technologies. In addition, Accelr8 licenses certain of its proprietary technology for use in applications outside of Accelr8's own products.

About SCHOTT

SCHOTT (www.schott.com) is an international technology-driven group that sees its core purpose as the lasting improvement of living and working conditions through special materials, components and high-tech solutions. Its main areas of focus are the household appliances industry, optics and electronics, pharmaceuticals and renewable energies. The SCHOTT Group has a presence in close proximity to its customers through highly efficient production and sales companies in all its major markets. It has 17,200 employees producing worldwide sales of approximately $2.2 billion. The company’s technological and economic expertise is closely linked with its social and ecological responsibility.

The division SCHOTT Nexterion Microarray Solutions (www.schott.com/nexterion) is specialized in high quality microarray products. As such, the company develops and markets a wide range of coated and uncoated glass substrates for DNA and protein microarraying under the brand Nexterion®. SCHOTT Nexterion continuously expands its product portfolio and has several innovative products and services in the development pipeline.

Certain statements in this news release may be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding future prospects and developments are based upon current expectations and involve certain risks and uncertainties that could cause actual results and developments to differ materially from the forward-looking statement, including those detailed in the company's filings with the Securities and Exchange Commission. Accelr8 does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events.

###